HLA-DRB1*0101 and *0405 as protective alleles in Japanese patients with renal cell carcinoma

Cancer Research

Volumn 57, Issue 4, 1997, Pages 742-746

  Özdemir, Enver ^a   Kakehi, Yoshiyuki ^a   Nakamura, Eijiro ^a   Kinoshita, Hidefumi ^a   Terachi, Toshiro ^a   Okada, Yusaku ^a   Yoshida, Osamu ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HLA DR ANTIGEN; HLA-DRB1 ANTIGEN;

ADULT; AGED; ALLELE; ARTICLE; CELL PROTECTION; CELL VIABILITY; CROSS REACTION; DNA TEMPLATE; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; IMMUNE RESPONSE; JAPAN; KIDNEY CARCINOMA; MAJOR CLINICAL STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; MALE; PRIORITY JOURNAL; CANCER STAGING; ETHNOLOGY; GENETICS; KIDNEY TUMOR; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; CARCINOMA, RENAL CELL; FEMALE; GENOTYPE; HLA-DR ANTIGENS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING;

EID: 0030614586     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Yoshida, O., Habuchi, T., and Ogawa, O. Recent advances in the molecular genetics of urogenital tumors. Int. J. Urol., 1: 1-16, 1994.
2. Ota, M., Seki, T., Fukushima, H., Tsuji, K., and Inoka, H. HLA-DRB1 genotyping by modified PCR-RFLP method combined with group-specific primers. Tissue Antigens, 39: 187-202, 1992.
3. Futami, S., Aoyama, N., Honsako, Y., Tamura, T., Morimoto, S., Nakashima, T., Ohmoto, A., Okano, H., Miyamoto, M., Inaba, H., Naruse, T., Nose, Y., and Kasuga, M. HLA-DRBI*1502 allele, subtype of DR15, is associated with susceptibility to ulcerative colitis and its progression. Dig. Dis. Sci., 40: 814-818, 1995.
4. Rukstalis, D. B., Bubley, G. J., Donahue, J. P., Richie, J. P., Seidman, J. G., and DeWolf, W. C. Regional loss of chromosome 6 in two urological malignancies. Cancer Res., 49: 5087-5090, 1989.
5. Kantor, A. F., McLaughlin, J. K., Blattner, W. A., Bach, F. H., Blot, W. J., Shuman, L. M., and Fraumeni, J. F. HLA antigens in renal cell carcinoma. Cancer Res., 43: 2330-2333, 1983.
6. Onishi, T., Machida, T., Nakajo, H., Hatano, T., and Sato, N. Frequency of major histocompatibility complex in Japanese patients with renal cell carcinoma. Cancer J., 16: 43-47, 1993.
7. Opelz, G., Mytilineos, J., Scherer, S., Dunckley, H., Trejaut, J., Chapman, J., Middleton, D., Savage, D., Fischer, O., Bignon, J. D., Bensa, J. C., Albert, E., and Noreen, H. Survival of DNA HLA-DR typed and matched cadaver kidney transplants. Lancet, 338: 461-463, 1991.
8. Mytilineos, J., Scherer, S., Dunckley, H., Trejaut, J., Chapman, J., Fischer, G., Fae, I., Middleton, D., Savage, D., Bignon, J. D., Bensa, J. C., Noreen, H., Albert, E., and Opelz, G. DNA HLA-DR typing results of 4000 kidney transplants. Transplantation (Baltimore), 55: 778-781, 1993.
9. Jordan, F., McWhinnie, A. J., Turner, S., Gavira, N., Calvert, A. A., Cleaver, S. A., Holman, R. H., Goldman, J. M., and Madrigal, J. A. Comparison of HLA-DRB1 typing by DNA-RFLP, PCR-SSO and PCR-SSP methods and their application in providing matched unrelated donors for bone marrow transplantation. Tissue Antigens, 45: 103-110, 1995.
10. Histological typing of kidney tumors. In: F. K. Mostofi (ed.), International Histological Classification of Tumors, No. 25. Geneva: WHO, 1981.
11. Robson, C. J., Churchill, B. M., and Anderson, W. The results of radical nephrectomy for renal cell carcinoma. J. Urol., 101: 297-301, 1969.
12. Hermanek, P., and Sobin, L. H. (eds.). Classification of Malignant Tumors, Ed 4. Berlin: Springer-Verlag, 1987.
13. Akaza, T., Imanishi, T., Fujiwara, K., Tokunaga, K., Juji, T., Yahiki, S., and Sonoda, S. HLA alleles and haplotype frequencies in Japanese. Transplant. Now, 7 (Suppl.): 87-99, 1994.
14. Perucho, M., Goldfarb, M., Shimizu, K., Lama, C., Fogh, J., and Wigler, M. Human tumor-derived cell lines contain common and different transforming genes. Cell, 27: 467-476, 1981.
15. Kakehi, Y., and Yoshida, O. Restriction fragment length polymorphism of the L-myc gene and susceptibility to metastasis in renal cancer patients. Int. J. Cancer, 43: 391-394, 1989.
16. Thomson, G. A. Review of theoretical aspects of HLA and disease associations. Theor. Popul. Biol., 20: 168-208, 1981.
17. Green, A. The epidemiologic approach to studies of association between HLA and disease. Tissue Antigens, 19: 245-268, 1982.
18. Ayala, F. J. The myth of Eve: molecular biology and human origins. Science (Washington DC), 270: 1930-1936, 1995.
19. Tiercy, J. M., Morel, J., Friedel, A. C., Zwahlen, F., Gebuhrer, L., Betuel, H., Jeannet, M., and Mach, B. Selection of unrelated donors for bone marrow transplantation is improved by HLA class II genotyping with oligonucleotide hybridization. Proc. Natl. Acad. Sci. USA, 88: 7121-7125, 1991.
20. Ichikawa, Y., Hashimoto, M., Nojima, M., Sata, M., Fujimoto, N., Kyo, M., Ishibashi, M., Ohshima, S., Amemiya, H., Fukunishi, T., Nagano, S., and Sonoda, T. The significant effect of HLA-DRBI matching on long-term kidney graft outcome. Transplantation (Baltimore), 56: 1368-1371, 1993.
21. Islam, M., Numaga, J., Matsuki, K., Fujino, Y., Maeda, H., and Masuda, K. Influence of HLA-DRBI gene variation on the clinical course of Vogt-Koyanagi-Harada disease. Invest. Ophtalmol. Visual Sci., 35: 752-756, 1994.
22. Nelson, J. L., Dugowson, C. E., Koepsell, T. D., Voigt, L. F., Brachoud, A. M., Barrington, R. A., Wener, M. H., and Hansen, J. A. Rheumatoid factor, HLA-DR4, and allelic variants of DRB1 in woman with recent-onset rheumatoid arthritis. Arthritis Rheum., 37: 673-680, 1994.
23. Dough, A., Faint, J., Salmon, M., Hassell, A., Wordsworth, P., Pilling, D., Birley, A., and Emery, P. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome. Arthritis Rheum., 37: 1166-1170, 1994.
24. Weyand, C. M., Hunder, N. N. H., Hicok, K. C., Hunder, G. G., and Goronzy, J. J. HLA-DRBI alleles in polymyalgia rheumatica, giant cell arthritis, and rheumatoid arthritis. Arthritis Rheum., 37: 514-520, 1994.
25. Kaneoka, H., Hsu, K. C., Takeda, Y., Sharp, G. C., and Huffman, R. W. Molecular genetic analysis of HLA-DR and HLA-DQ genes among anti-U1-70-kd autoantibody-positive connective tissue disease patients. Arthritis Rheum., 35: 83-94, 1992.
26. Lee, J. E., Reveille, J. D., Ross, M. I., and Platsoucas, C. D. HLA-DQB*0301 association with increased cutaneous melanoma risk. Int. J. Cancer, 59: 510-513, 1994.
27. Glew, S. S., Stern, P. S., Davidson, J. A., and Dyer, P. A. HLA antigens and cervical carcinoma. Nature (Lond.), 356: 22, 1992.
28. Buttler, B. P., Novick, A. C., Miller, D. P., Campbell, S. A., and Light, M. R. Management of small unilateral renal cell carcinomas: radical versus nephron-sparing surgery. Urology, 45: 34-40, 1995.